Wordt geladen...
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5mg in contraception
BACKGROUND: LNG-IUS 13.5mg (total content) is a low-dose levonorgestrel intrauterine system for up to three years of use. This analysis evaluated the cost-effectiveness of LNG-IUS 13.5mg in comparison with short-acting reversible contraceptive (SARC) methods in a cohort of young women in the US from...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019682/ https://ncbi.nlm.nih.gov/pubmed/24576791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2013.10.019 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|